Relmada Therapeutics, Inc. Share Price
RLMDRelmada Therapeutics, Inc. Stock Performance
Open $7.19 | Prev. Close $7.38 | Circuit Range N/A |
Day Range $6.91 - $7.33 | Year Range $0.27 - $7.83 | Volume 1,44,546 |
Average Traded $7.08 |
Relmada Therapeutics, Inc. Share Price Chart
About Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. It also develops REL-P11, a modified-release formulation of psilocybin that has completed Phase 1 safety study for the treatment of metabolic disease. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Relmada Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
20-Apr-26 | $7.42 | $7.36 | -1.60% |
17-Apr-26 | $7.03 | $7.48 | +6.93% |
16-Apr-26 | $7.13 | $7.00 | -2.64% |
15-Apr-26 | $7.12 | $7.18 | +0.21% |
14-Apr-26 | $7.47 | $7.17 | -2.65% |
13-Apr-26 | $7.12 | $7.37 | +1.45% |
10-Apr-26 | $7.76 | $7.26 | -4.47% |
FAQs on Relmada Therapeutics, Inc. Share Price
Can I buy Relmada Therapeutics, Inc. shares in India?
What is the share price of Relmada Therapeutics, Inc.?
What is the 5 year returns of Relmada Therapeutics, Inc.?
What are the high & low stock price of Relmada Therapeutics, Inc. today?
What is the 52-week high and low of Relmada Therapeutics, Inc. stock?